AR058728A1 - Derivados de aril-isoxazol-4-il-imidazo[1,5-a]piridina, metodo de preparacion,medicamentos que los contienen y usos en el tratamiento de trastornos cognitivos. - Google Patents
Derivados de aril-isoxazol-4-il-imidazo[1,5-a]piridina, metodo de preparacion,medicamentos que los contienen y usos en el tratamiento de trastornos cognitivos.Info
- Publication number
- AR058728A1 AR058728A1 ARP060105770A ARP060105770A AR058728A1 AR 058728 A1 AR058728 A1 AR 058728A1 AR P060105770 A ARP060105770 A AR P060105770A AR P060105770 A ARP060105770 A AR P060105770A AR 058728 A1 AR058728 A1 AR 058728A1
- Authority
- AR
- Argentina
- Prior art keywords
- lower alkyl
- isoxazol
- imidazo
- treatment
- links
- Prior art date
Links
- 208000010877 cognitive disease Diseases 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 5
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 125000000592 heterocycloalkyl group Chemical group 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 abstract 1
- 239000002475 cognitive enhancer Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 abstract 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 102000005962 receptors Human genes 0.000 abstract 1
- 108020003175 receptors Proteins 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La presente se refiere a derivados de aril-isoxazol-4-il-imidazo[1,5-a]piridina de la formula (1) en la que R1 es H, halogeno, hidroxi, alquilo inferior, benciloxi o -O-(CH2)-(CO)-heteroarilo de 5 o 6 eslabones opcionalmente sustituido por arilo y alquilo inferior; R2 es H, alquilo inferior o -(CO)-Ra; R3 es H, halogeno, ciano, alquilo inferior, o -(CO)-Ra; Ra es hidroxi, alcoxi inferior, NR'Rö, en el que R' y Rö con independencia entre sí son H, cicloalquilo, heterocicloalquilo de 5 o 6 eslabones o alquilo inferior opcionalmente sustituido por cicloalquilo, ciano, heterocicloalquilo de 5 o 6 eslabones o heteroarilo de 5 o 6 eslabones; y a sales de adicion de ácido farmacéuticamente aceptables de los mismos. Se ha encontrado que este grupo de compuestos posee una gran afinidad y selectividad para los sitios de fijacion del receptor alfa5 del GABA y puede ser util como mejorador cognitivo o para el tratamiento de trastornos cognitivos, tales como la enfermedad de Alzheimer.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05112988 | 2005-12-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR058728A1 true AR058728A1 (es) | 2008-02-20 |
Family
ID=37909303
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP060105770A AR058728A1 (es) | 2005-12-27 | 2006-12-26 | Derivados de aril-isoxazol-4-il-imidazo[1,5-a]piridina, metodo de preparacion,medicamentos que los contienen y usos en el tratamiento de trastornos cognitivos. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7399769B2 (es) |
| EP (1) | EP1968977B1 (es) |
| JP (1) | JP4864982B2 (es) |
| KR (1) | KR101033719B1 (es) |
| CN (1) | CN101346377B (es) |
| AR (1) | AR058728A1 (es) |
| AT (1) | ATE537171T1 (es) |
| AU (1) | AU2006331363B2 (es) |
| BR (1) | BRPI0620760A2 (es) |
| CA (1) | CA2633536A1 (es) |
| ES (1) | ES2376357T3 (es) |
| IL (1) | IL192236A0 (es) |
| NO (1) | NO20082748L (es) |
| RU (1) | RU2420527C2 (es) |
| TW (1) | TWI324156B (es) |
| WO (1) | WO2007074089A1 (es) |
| ZA (1) | ZA200805354B (es) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101351461B (zh) * | 2005-12-27 | 2011-09-07 | 弗·哈夫曼-拉罗切有限公司 | 芳基-异*唑-4-基-咪唑衍生物 |
| JP5416103B2 (ja) * | 2007-06-22 | 2014-02-12 | エフ．ホフマン−ラ ロシュ アーゲー | イソオキサゾール−イミダゾール誘導体 |
| AU2008333326B2 (en) | 2007-12-04 | 2013-05-30 | F. Hoffmann-La Roche Ag | Isoxazolo-pyridine derivatives |
| US20150374705A1 (en) | 2012-02-14 | 2015-12-31 | Shanghai Institues for Biological Sciences | Substances for treatment or relief of pain |
| WO2014001278A1 (en) | 2012-06-26 | 2014-01-03 | Aniona Aps | A phenyl triazole derivative and its use for modulating the gabaa receptor complex |
| JP6223443B2 (ja) | 2012-06-26 | 2017-11-01 | サニオナ・エイピイエス | フェニルトリアゾール誘導体及びｇａｂａａ受容体複合体を調節するための該フェニルトリアゾール誘導体の使用 |
| WO2014001280A1 (en) | 2012-06-26 | 2014-01-03 | Aniona Aps | A phenyl triazole derivative and its use for modulating the gabaa receptor complex |
| KR20150033678A (ko) | 2012-06-26 | 2015-04-01 | 사니오나 에이피에스 | 페닐 트리아졸 유도체 및 이의 gabaa 수용체 복합체 조절용 용도 |
| WO2014001279A1 (en) | 2012-06-26 | 2014-01-03 | Aniona Aps | A phenyl triazole derivative and its use for modulating the gabaa receptor complex |
| CN106488915B (zh) | 2014-02-13 | 2020-10-02 | 因赛特公司 | 作为lsd1抑制剂的环丙胺 |
| US9527835B2 (en) | 2014-02-13 | 2016-12-27 | Incyte Corporation | Cyclopropylamines as LSD1 inhibitors |
| SG10201806849WA (en) | 2014-02-13 | 2018-09-27 | Incyte Corp | Cyclopropylamines as lsd1 inhibitors |
| US9695168B2 (en) | 2014-07-10 | 2017-07-04 | Incyte Corporation | Substituted imidazo[1,5-α]pyridines and imidazo[1,5-α]pyrazines as LSD1 inhibitors |
| US9695167B2 (en) | 2014-07-10 | 2017-07-04 | Incyte Corporation | Substituted triazolo[1,5-a]pyridines and triazolo[1,5-a]pyrazines as LSD1 inhibitors |
| TW201613925A (en) | 2014-07-10 | 2016-04-16 | Incyte Corp | Imidazopyrazines as LSD1 inhibitors |
| US9944647B2 (en) | 2015-04-03 | 2018-04-17 | Incyte Corporation | Heterocyclic compounds as LSD1 inhibitors |
| UA126277C2 (uk) | 2015-08-12 | 2022-09-14 | Інсайт Корпорейшн | Солі інгібітору lsd1 |
| BR102019014802A2 (pt) | 2018-07-20 | 2020-02-04 | Boehringer Ingelheim Int | difluorometil-fenil triazóis |
| US10968200B2 (en) | 2018-08-31 | 2021-04-06 | Incyte Corporation | Salts of an LSD1 inhibitor and processes for preparing the same |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE258554T1 (de) * | 1999-10-08 | 2004-02-15 | Gruenenthal Gmbh | Bicyclische imidazo-3-yl-aminderivate |
| WO2001034603A2 (en) | 1999-11-12 | 2001-05-17 | Neurogen Corporation | Bicyclic and tricyclic heteroaromatic compounds |
| EP1448561B1 (en) * | 2001-11-20 | 2008-02-20 | Eli Lilly And Company | Beta 3 adrenergic agonists |
-
2006
- 2006-12-18 AT AT06841391T patent/ATE537171T1/de active
- 2006-12-18 AU AU2006331363A patent/AU2006331363B2/en not_active Ceased
- 2006-12-18 RU RU2008125040/04A patent/RU2420527C2/ru not_active IP Right Cessation
- 2006-12-18 US US11/640,768 patent/US7399769B2/en not_active Expired - Fee Related
- 2006-12-18 WO PCT/EP2006/069792 patent/WO2007074089A1/en not_active Ceased
- 2006-12-18 CA CA002633536A patent/CA2633536A1/en not_active Abandoned
- 2006-12-18 KR KR1020087015509A patent/KR101033719B1/ko not_active Expired - Fee Related
- 2006-12-18 BR BRPI0620760-0A patent/BRPI0620760A2/pt not_active IP Right Cessation
- 2006-12-18 EP EP06841391A patent/EP1968977B1/en not_active Not-in-force
- 2006-12-18 CN CN2006800491806A patent/CN101346377B/zh not_active Expired - Fee Related
- 2006-12-18 JP JP2008547940A patent/JP4864982B2/ja not_active Expired - Fee Related
- 2006-12-18 ES ES06841391T patent/ES2376357T3/es active Active
- 2006-12-25 TW TW095148805A patent/TWI324156B/zh not_active IP Right Cessation
- 2006-12-26 AR ARP060105770A patent/AR058728A1/es not_active Application Discontinuation
-
2008
- 2008-06-13 NO NO20082748A patent/NO20082748L/no not_active Application Discontinuation
- 2008-06-16 IL IL192236A patent/IL192236A0/en unknown
- 2008-06-19 ZA ZA200805354A patent/ZA200805354B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TWI324156B (en) | 2010-05-01 |
| US20070191421A1 (en) | 2007-08-16 |
| IL192236A0 (en) | 2008-12-29 |
| JP4864982B2 (ja) | 2012-02-01 |
| AU2006331363B2 (en) | 2012-07-05 |
| JP2009521517A (ja) | 2009-06-04 |
| US7399769B2 (en) | 2008-07-15 |
| CN101346377B (zh) | 2011-05-11 |
| EP1968977A1 (en) | 2008-09-17 |
| NO20082748L (no) | 2008-09-24 |
| EP1968977B1 (en) | 2011-12-14 |
| ATE537171T1 (de) | 2011-12-15 |
| WO2007074089A1 (en) | 2007-07-05 |
| ZA200805354B (en) | 2009-10-28 |
| BRPI0620760A2 (pt) | 2011-11-22 |
| ES2376357T3 (es) | 2012-03-13 |
| TW200734328A (en) | 2007-09-16 |
| AU2006331363A1 (en) | 2007-07-05 |
| KR20080072072A (ko) | 2008-08-05 |
| RU2008125040A (ru) | 2010-02-10 |
| RU2420527C2 (ru) | 2011-06-10 |
| CA2633536A1 (en) | 2007-07-05 |
| KR101033719B1 (ko) | 2011-05-09 |
| CN101346377A (zh) | 2009-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR058728A1 (es) | Derivados de aril-isoxazol-4-il-imidazo[1,5-a]piridina, metodo de preparacion,medicamentos que los contienen y usos en el tratamiento de trastornos cognitivos. | |
| AR059016A4 (es) | Derivados de aril-isoxazol-4-il-imidazo[1,2-a]piridina, metodo de preparacion, medicamentos que los contienen y usos en el tratamiento de trastornos cognitivos. | |
| JP7394824B2 (ja) | 免疫調節剤としての複素環化合物 | |
| ES2921020T3 (es) | Compuestos de indol sustituidos con [1,2,4]triazolo[4,3-a]piridinilo | |
| ES2937236T3 (es) | Derivados de dihidro-pirrolo-piridina | |
| KR20210018282A (ko) | PD-L1 면역조절제로서의 테트라하이드로-이미다조[4,5-c]피리딘 유도체 | |
| CN112004802B (zh) | 作为神经元组胺受体-3拮抗剂的化合物及其用途 | |
| ES2834027T3 (es) | Compuestos de N-pirrolidinil, N'-pirazolil-urea como inhibidores de TrkA quinasa | |
| ES3012114T3 (en) | Substituted piperidino compounds and related methods of treatment | |
| JP2021511342A (ja) | 癌処置のためのｂｃｌ−２タンパク質分解剤 | |
| BR112020019700A2 (pt) | Compostos heterocíclicos como imunomoduladores | |
| AR052902A1 (es) | Derivados de piridazina, composicion farmaceutica que los contiene y su uso como agentes terapeuticos para enfermedades mediadas por la estearoil-coa desaturasa | |
| CA3005737A1 (en) | Inhibitors of cxcr2 | |
| AR078756A1 (es) | Moduladores alostericos positivos (map) | |
| TW201625558A (zh) | 磷脂醯肌醇３－激酶抑制劑 | |
| AR059686A1 (es) | Piperazinas terapeuticas | |
| AR073920A1 (es) | Derivados urea de nortropanos sustituidos, medicamentos que contienen dichos compuestos , su uso en el tratamiento de enfermedades mediadas por la inhibicion de la enzima 11beta-hidroxiesteroide deshidrogenasa y proceso para su preparacion. | |
| AR046309A1 (es) | Derivados de dihidrobenzofuranilo alcanamina, metodos para su preparacion, composiciones farmaceuticas que los contienen y su uso en el tratamiento de trastornos del sistema nervioso central. | |
| PE20091095A1 (es) | Moduladores de gamma secretasa | |
| EP2417135A1 (en) | Substituted triazolopyridines and analogs thereof | |
| AR043875A1 (es) | Derivados de quinazolina, proceso para su preparacion y composiciones farmaceuticas que los contienen | |
| ES2714100T3 (es) | Compuestos de quinolina fusionados como inhibidores de mTor, pi3k | |
| AR054786A1 (es) | (6-fluor-benzol(1,3) dioxolil)-morfolin-4-il-metanomas, moduladoras del receptor cb1 | |
| KR102637541B1 (ko) | 화합물, 조성물 및 방법 | |
| ES2706475T3 (es) | Nuevos derivados de bencimidazol como agentes antihistamínicos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |